Rescheduled to Friday, October 10, 2025 – (9-10 a.m. PT); (10-11 a.m. MT); (11 a.m.-12 p.m. CT); (12-1 p.m. ET)
REGISTER HERE 

Speakers: Ashley M. Ebersole, MD, MS, FAAP, Nationwide Children’s Hospital/The Ohio State University; Antoinette Nguyen, MD, MPH, FACOG, Emory University; Cambray Smith, UNC Chapel Hill

Session Description: This panel brings together multidisciplinary experts to discuss updated CDC contraceptive guidelines from the U.S. Selected Practice Recommendations for Contraceptive Use, 2024 (U.S. SPR) on use of medications for IUD placement and the evidence for these recommendations as well as issues around patient concerns related to online conversations about IUD placement/use, and the importance in this context of reinforcing autonomy, equity, and person-centered care for pain management with intrauterine device (IUD) placement, including adolescents. As healthcare providers strive to provide person-centered care in an increasingly complex information environment, we need to ensure that we are supporting patients and providing evidence-based care while addressing patients’ concerns. The experience of pain is individualized and influenced by many factors. This session will discuss the common concern of pain and anxiety during IUD placement and the importance of honoring autonomy and preferences. Using an interactive format, the experts will present case studies, conduct polling, and share and solicit from the audience best practices and insights on how to implement the updated recommendations into different clinical settings and practices.

This panel discussion can have substantial impact on the field of family planning as CDC contraceptive guidelines are key federal recommendations that promote high quality contraceptive services and person-centered contraceptive care. The last comprehensive update for the U.S. SPR was published in 2016.1 It is crucial to identify opportunities for SAHM members to learn about updated 2024 CDC guideline recommendations as SAHM members are a key and important audience in the dissemination and implementation of the recommendations. This topic is also especially relevant to SAHM members given the rise in social media content on patient experiences with IUD placement, which can affect patient perception and use of IUD as well as trust in healthcare providers and systems.2,3

Clinical practice: Evidence-based guidance can support health care providers when providing person-centered counseling and contraceptive services, including counseling4 and provision of pain management for IUD placement. This panel will discuss updated clinical practice guidelines and recommendations that directly impact counseling and provision of IUDs.

Education and training: This panel’s focus on updated CDC contraceptive guidelines will affect the development of new curricula for medical education. It is important that future healthcare providers are aware of these updates and be able to disseminate and implement them into their future clinical practice.

Patient-centered care: CDC acknowledges the paramount importance of personal autonomy in contraceptive decision-making. The goal of CDC contraceptive recommendations is to remove unnecessary medical barriers to accessing and using contraception and to support the provision of person-centered contraceptive counseling and services. U.S. SPR recommendations can be used to support a person’s contraceptive decision-making. The experience of pain is individualized and influenced by many factors. This session will discuss the common concern of pain and anxiety during IUD placement and the importance of honoring autonomy and preferences.

This panel aligns with SAHM’s DEI goal in several ways. This panel consists of a racially and ethnically diverse group of experts from different disciplines (e.g., OB/Gyn, Adolescent Medicine, epidemiology), different geographic regions (e.g., Midwest, Southeast), and different clinical settings (e.g., academic, pediatric hospital, public safety net hospital). We will discuss how federal guidelines are one tool that can be used to address health inequities in contraceptive care by removing unnecessary medical barriers to accessing and using contraception and supporting the provision of person-centered contraceptive counseling and services.

Learning Objectives:

1. 1. Describe updates to CDC contraceptive guidelines on medications for intrauterine device (IUD) placement in U.S. Selected Practice Recommendations for Contraceptive Use, 2024 (U.S. SPR) and the evidence base for these recommendations.
   2. Discuss patient concerns related to online conversations about IUD pain management, and the importance of health care providers supporting autonomy, equity, and person-centered care for pain management with IUD placement.
   3. List 3 strategies to improve pain management for IUD placement in different clinical settings.